Abingworth as of Dec. 31, 2021
Portfolio Holdings for Abingworth
Abingworth holds 20 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 24.0 | $99M | 4.2M | 23.79 | |
| Vera Common (VERA) | 19.0 | $79M | 3.0M | 26.53 | |
| Jasper Common | 10.7 | $44M | 5.6M | 7.84 | |
| eFFECTOR Common | 9.7 | $40M | 4.8M | 8.28 | |
| Adicet Common (ACET) | 8.9 | $37M | 2.1M | 17.44 | |
| Phathom Common (PHAT) | 5.7 | $24M | 1.2M | 19.62 | |
| Sierra Oncology Common | 4.6 | $19M | 877k | 21.73 | |
| Reneo Common (RPHM) | 4.3 | $18M | 2.1M | 8.55 | |
| Verona Sponds Adr (VRNA) | 4.0 | $16M | 2.5M | 6.64 | |
| Sientra Common | 2.1 | $8.6M | 2.3M | 3.66 | |
| Spruce Bio Common | 1.9 | $8.0M | 1.8M | 4.44 | |
| Nucana Adr (NCNA) | 1.9 | $7.9M | 3.3M | 2.38 | |
| Paratek Common | 1.1 | $4.7M | 1.0M | 4.47 | |
| Soleno Common | 1.0 | $4.2M | 10M | 0.41 | |
| Exicure Common | 0.3 | $1.4M | 7.0M | 0.20 | |
| Aeglea Common | 0.3 | $1.1M | 241k | 4.75 | |
| Molecular Templates Common | 0.2 | $780k | 200k | 3.90 | |
| Cymabay Common | 0.1 | $442k | 131k | 3.37 | |
| Obseva Common | 0.0 | $174k | 88k | 1.98 | |
| Ocugen Common | 0.0 | $32k | 7.1k | 4.50 |
